Brief: Eqs-News Formycon Aflibercept Biosimilars Ahzantive® And Baiama® Are Now Available In The European Union
19/05/2026 05:33
May 19 (Reuters) - Formycon AG FYB.DE:- EQS-NEWS: FORMYCON EXPANDS COMMERCIAL PORTFOLIO: AFLIBERCEPT BIOSIMILARS AHZANTIVE® AND BAIAMA® ARE NOW AVAILABLE IN THE EUROPEAN UNION FYB203 (AFLIBERCEPT) PREFILLED SYRINGES LAUNCHED AS AHZANTIVE AND BAIAMA IN EU AHZANTIVE AND BAIAMA LAUNCHED IN GERMANY, FRANCE, ITALY ON MAY 15, 2026 ROLL OUT OF AHZANTIVE AND BAIAMA TO EXPAND IN CENTRAL AND EASTERN EUROPE PHASED ROLLOUT OF AHZANTIVE AND BAIAMA IN KEY EUROPEAN MARKETS Source text: ID:nEQ93Zzvla Further company coverage: FYB.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Formycon AG
See all newsGermany's Formycon Q1 revenue more than doubles, EBITDA loss narrows
Brief: Formycon Q1 Revenue EUR 13.1 Million
Brief: Eqs-News Formycon Aflibercept Biosimilars Ahzantive® And Baiama® Are Now Available In The European Union
Brief: Formycon AG Reports FY25 Group Revenue EUR 44.5 Million
Brief: Formycon Says Co Secures License Date For Fyb203 Biosimilar In Europe & Further Territories